Terms: = Pancreatic cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
6 results:
1. Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer.
Fiore M; Trodella L; Valeri S; Borzomati D; Floreno B; Ippolito E; Trecca P; Trodella LE; D'Angelillo RM; Ramella S; Coppola R
Radiat Oncol; 2015 Dec; 10():255. PubMed ID: 26670587
[TBL] [Abstract] [Full Text] [Related]
2. Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels.
Liu K; Qin CK; Wang ZY; Liu SX; Cui XP; Zhang DY
Asian Pac J Cancer Prev; 2012; 13(3):847-50. PubMed ID: 22631659
[TBL] [Abstract] [Full Text] [Related]
3. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
4. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.
Czito BG; Willett CG; Bendell JC; Morse MA; Tyler DS; Fernando NH; Mantyh CR; Blobe GC; Honeycutt W; Yu D; Clary BM; Pappas TN; Ludwig KA; Hurwitz HI
J Clin Oncol; 2006 Feb; 24(4):656-62. PubMed ID: 16446337
[TBL] [Abstract] [Full Text] [Related]
5. Recombinant anti-egfr immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.
Bruell D; Bruns CJ; Yezhelyev M; Huhn M; Müller J; Ischenko I; Fischer R; Finnern R; Jauch KW; Barth S
Int J Mol Med; 2005 Feb; 15(2):305-13. PubMed ID: 15647848
[TBL] [Abstract] [Full Text] [Related]
6. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.
Yamanaka Y; Friess H; Kobrin MS; Buchler M; Beger HG; Korc M
Anticancer Res; 1993; 13(3):565-9. PubMed ID: 8317885
[TBL] [Abstract] [Full Text] [Related]